Class Action Lawsuit Filed Against Hims & Hers Health, Inc.
A class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) by Pomerantz LLP, alleging securities fraud and other unlawful business practices involving the company's officers or directors. Investors who purchased shares during a specified period are encouraged to contact the firm before November 2, 2026, for potential inclusion as lead plaintiffs. The lawsuit follows an earlier action from the Federal Trade Commission (FTC), which accused Hims & Hers of deceptive practices related to privacy and billing policies. The FTC claimed that sensitive health data was shared with third-party advertising platforms like Meta Platforms Inc. (ticker: META) and Snap Inc. (ticker: SNAP). This news led to a 14.73% drop in the company's stock price on July 29, 2026. Pomerantz LLP is one of the leading firms specializing in corporate litigation and has secured significant damages for class members over decades.
Topics: data privacy deceptive advertising FTC lawsuit securities fraud